Dipeptide/Oligopeptides Production
Ajinomoto recently developed a powerful biopharmaceutical technology for the production of small peptides. The process uses fermentation to produce an enzyme that subsequently bonds single amino acids into di-, tri-, and oligopeptides.
Ajinomoto's newly discovered enzyme system possesses a number of significant advantages over existing industrial methods of creating dipeptides/oligopeptides:
- Faster reaction rates
- Higher yields
- Broad substrate specificity
- Elimination of racemization separations
- No need for the use of protected amino acid with costly deprotection steps
Ajinomoto's innovative and highly effective enzymation process can be used to produce a wide range of diverse short-length peptides. To see how our procees can help you improve amino acid stability or improve your cell culture operation please contact Ajinomoto sales.

Oligopeptides Production
- Oligopeptides can also be synthesized using amino acid esters as acyl donors and peptides as nucleophiles.
- Most peptides tested as nucleophiles attacked the amino acid methyl esters well, producing excellent yields of the corresponding oligopeptides
| |
|
|
(mM) |
| |
L-Ala |
L-Ala-L-Ala |
28.7 |
| |
L-Ala-L-Ala |
L-Ala-L-Ala-L-Ala |
57.5 |
| |
L-Ala-L-Ala-L-Ala |
L-Ala-L-Ala-L-Ala-L-Ala |
44.5 |
| |
L-Ala-L-Ala-L-Ala-L-Ala |
L-Ala-L-Ala-L-Ala-L-Ala-L-Ala |
34.8 |
| |
L-Ala-L-Ala-L-Ala-L-Ala-L-Ala |
L-Ala-L-Ala-L-Ala-L-Ala-L-Ala-L-Ala |
1.4* |
| L-Ala-OMe |
L-Ala-L-Gln |
L-Ala-L-Ala-L-Gln |
15.2 |
| |
Gly-L-Ala |
L-Ala-Gly-L-Ala |
25.9 |
| |
Gly-Gly |
L-Ala-Gly-Gly |
41.7 |
| |
L-His-L-Ala |
L-Ala-L-His-L-Ala |
55.9 |
| |
L-Leu-L-Ala |
L-Ala-L-Leu-L-Ala |
48.3 |
| |
L-Phe-L-Ala |
L-Ala-L-Phe-L-Ala |
49.7 |
| |
L-Phe-Gly |
L-Ala-L-Phe-Gly |
43.7 |
| |
L-Ala-L-Tyr |
Gly-L-Ala-L-Tyr |
1.7 |
| Gly-OMe |
Gly-L-Gln |
Gly-Gly-L-Gln |
7.2 |
| |
Gly-L-Tyr-L-Ala |
Gly-Gly-L-Tyr-L-Ala |
44.2 |
| L-Thr-OMe |
Gly-Gly |
L-Thr-Gly-Gly |
83.0 |
Copyright © 1996-
AJINOMOTO Co., Inc.